AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 14552533 — intervention group
Group type: COMPARATOR
Intervention: Peripheral neuromotor apparatus lesions
Number of subjects: 0
Study 11023935 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol
Number of subjects: 21
Study 11023935 — intervention group
Group type: EXPERIMENTAL
Intervention: Perindopril
Number of subjects: 21
Study 11023935 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 21
Study 9010122 — intervention group
Group type: EXPERIMENTAL
Intervention: Desipramine treatment (N = 6)
Number of subjects: 10
Study 9010122 — intervention group
Group type: COMPARATOR
Intervention: Placebo lead-in (N = 4)
Number of subjects: 10
Study 1324443 — intervention group
Group type: EXPERIMENTAL
Intervention: Polydioxanone sutures
Number of subjects: 120
Study 1324443 — intervention group
Group type: COMPARATOR
Intervention: Different synthetic absorbable sutures and techniques
Number of subjects: 120
Study 30798568 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin E‐Selenium‐Folic Acid (Vit E‐Se‐FA) supplementation for six months
Number of subjects: 60
Study 30798568 — intervention group
Group type: COMPARATOR
Intervention: Control group with supplemental treatment
Number of subjects: 60
Study 29903796 — intervention group
Group type: EXPERIMENTAL
Intervention: BreastScreen invitations and promotion of screening for women aged 70-74
Number of subjects: 34
Study 26952907 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-hospital ticagrelor
Number of subjects: 1629
Study 25457417 — intervention group
Group type: EXPERIMENTAL
Intervention: +25% of desired stride length
Number of subjects: 19
Study 25457417 — intervention group
Group type: EXPERIMENTAL
Intervention: Shorter strides
Number of subjects: 19
Study 25457417 — intervention group
Group type: EXPERIMENTAL
Intervention: Greater upward and lateral momentum (toward third base)
Number of subjects: 19
Study 25457417 — intervention group
Group type: EXPERIMENTAL
Intervention: Insufficient total body momentum in the intended throwing direction
Number of subjects: 19
Study 22313169 — intervention group
Group type: EXPERIMENTAL
Intervention: Face IT (computerised CBT-based intervention)
Number of subjects: 83
Study 22313169 — intervention group
Group type: EXPERIMENTAL
Intervention: Face-to-face CBT-based delivery
Number of subjects: 83
Study 22313169 — intervention group
Group type: COMPARATOR
Intervention: Non-intervention control group
Number of subjects: 83
Study 20221859 — intervention group
Group type: EXPERIMENTAL
Intervention: D5W (5% dextrose in water) injected intravascularly
Number of subjects: 16
Study 20221859 — intervention group
Group type: EXPERIMENTAL
Intervention: D5W (5% dextrose in water) injected perineurally
Number of subjects: 16
Study 17828040 — intervention group
Group type: EXPERIMENTAL
Intervention: Integra
Number of subjects: 20
Study 17828040 — intervention group
Group type: COMPARATOR
Intervention: Autograft-allograft technique
Number of subjects: 20
Study 14962651 — intervention group
Group type: EXPERIMENTAL
Intervention: Children with HSC and OCTD (n:13)
Number of subjects: 49
Study 14962651 — intervention group
Group type: EXPERIMENTAL
Intervention: Children with HSC without OCTD (n:7)
Number of subjects: 49
Study 14962651 — intervention group
Group type: COMPARATOR
Intervention: Control group (n:31)
Number of subjects: 49
Study 11409225 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised exercise program
Number of subjects: 21
Study 11409225 — intervention group
Group type: COMPARATOR
Intervention: Home-based exercise program
Number of subjects: 21
Study 11409225 — intervention group
Group type: COMPARATOR
Intervention: Supervised exercise program and Home-based exercise program
Number of subjects: 21
Study 9879163 — intervention group
Group type: EXPERIMENTAL
Intervention: Music started 10 min before the procedure and maintained until 10 min after its conclusion (Group 1)
Number of subjects: 193
Study 9879163 — intervention group
Group type: COMPARATOR
Intervention: Music begun at the conclusion of lithotripsy and continued for 10 min (Group 2)
Number of subjects: 193
Study 7981429 — intervention group
Group type: EXPERIMENTAL
Intervention: MK-679 75 mg
Number of subjects: 12
Study 7981429 — intervention group
Group type: EXPERIMENTAL
Intervention: MK-679 250 mg
Number of subjects: 12
Study 7981429 — intervention group
Group type: EXPERIMENTAL
Intervention: MK-679 500 mg
Number of subjects: 12
Study 7981429 — intervention group
Group type: EXPERIMENTAL
Intervention: MK-679 250 mg (oral) + 14C-MK-679 1 mg (IV)
Number of subjects: 12
Study 2595746 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenobarbital (200 mg)
Number of subjects: 8
Study 2595746 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 939331 — intervention group
Group type: EXPERIMENTAL
Intervention: Chloroform‐methanol (2:1 v/v)
Number of subjects: 0
Study 939331 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetone or diethyl ether
Number of subjects: 0
Study 939331 — intervention group
Group type: COMPARATOR
Intervention: n‐hexane
Number of subjects: 0
Study 29230635 — intervention group
Group type: EXPERIMENTAL
Intervention: Growth hormone (GH) substitution
Number of subjects: 47
Study 29230635 — intervention group
Group type: COMPARATOR
Intervention: Non GH-treated patients
Number of subjects: 47
Study 27647263 — intervention group
Group type: EXPERIMENTAL
Intervention: Selenium supplementation (200 µg/d Se as Se yeast)
Number of subjects: 60
Study 27647263 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 25017487 — intervention group
Group type: EXPERIMENTAL
Intervention: Everolimus with very low tacrolimus exposure (1.5-3 ng/mL)
Number of subjects: 46
Study 25017487 — intervention group
Group type: EXPERIMENTAL
Intervention: Everolimus with low tacrolimus exposure (4-7 ng/mL)
Number of subjects: 46
Study 25017487 — intervention group
Group type: EXPERIMENTAL
Intervention: Everolimus with tacrolimus
Number of subjects: 46
Study 25017487 — intervention group
Group type: COMPARATOR
Intervention: Everolimus with cyclosporine (from A2307 trial)
Number of subjects: 46
Study 22162538 — intervention group
Group type: EXPERIMENTAL
Intervention: HX575 (100 IU/kg)
Number of subjects: 149
Study 22162538 — intervention group
Group type: COMPARATOR
Intervention: Comparator epoetin alfa
Number of subjects: 149
Study 20643827 — intervention group
Group type: EXPERIMENTAL
Intervention: Selenium-enriched yeast (SY) supplementation (247 microg/d)
Number of subjects: 36
Study 20643827 — intervention group
Group type: COMPARATOR
Intervention: Placebo (nonenriched yeast)
Number of subjects: 36
Study 18984650 — intervention group
Group type: EXPERIMENTAL
Intervention: Montelukast 4 mg sachets, daily from hospital admission until discharge
Number of subjects: 53
Study 18984650 — intervention group
Group type: COMPARATOR
Intervention: Placebo, daily from hospital admission until discharge
Number of subjects: 53
Study 18984650 — intervention group
Group type: EXPERIMENTAL
Intervention: Montelukast 4 mg sachets
Number of subjects: 53
Study 18984650 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 53
Study 15642753 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse home visiting asthma education program (8 lessons)
Number of subjects: 55
Study 15642753 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse home visiting asthma education program
Number of subjects: 55
Study 12842372 — intervention group
Group type: EXPERIMENTAL
Intervention: 7-valent pneumococcal conjugate vaccine followed by 23-valent pneumococcal polysaccharide vaccine
Number of subjects: 383
Study 12842372 — intervention group
Group type: COMPARATOR
Intervention: Hepatitis A or B vaccines
Number of subjects: 383
Study 10999260 — intervention group
Group type: EXPERIMENTAL
Intervention: Focusing on the ball leaving the racket (effect) during tennis ball hitting
Number of subjects: 2
Study 10999260 — intervention group
Group type: EXPERIMENTAL
Intervention: Focusing on the club (technique-related effect) during golf ball hitting
Number of subjects: 2
Study 10999260 — intervention group
Group type: COMPARATOR
Intervention: Focusing on the ball coming toward them (antecedent) during tennis ball hitting
Number of subjects: 2
Study 10999260 — intervention group
Group type: COMPARATOR
Intervention: Focusing on the ball trajectory (outcome) during golf ball hitting
Number of subjects: 2
Study 8838484 — intervention group
Group type: COMPARATOR
Intervention: 75 micrograms gestodene + 30 micrograms ethinyl estradiol (EE)
Number of subjects: 2767
Study 8838484 — intervention group
Group type: EXPERIMENTAL
Intervention: 150 micrograms desogestrel + 30 micrograms ethinyl estradiol (EE)
Number of subjects: 2767
Study 8838484 — intervention group
Group type: EXPERIMENTAL
Intervention: 150 micrograms desogestrel + 20 micrograms ethinyl estradiol (EE)
Number of subjects: 2767
Study 8838484 — intervention group
Group type: EXPERIMENTAL
Intervention: Desogestrel-containing preparation
Number of subjects: 2767
Study 1299421 — intervention group
Group type: EXPERIMENTAL
Intervention: alpha‐2a Interferon (IFN) (100,000 I.U. in 1 ml)
Number of subjects: 13
Study 1299421 — intervention group
Group type: COMPARATOR
Intervention: Saline
Number of subjects: 13
Study 1299421 — intervention group
Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 13
Study 6493939 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-observation
Number of subjects: 0
Study 6493939 — intervention group
Group type: COMPARATOR
Intervention: Paradoxical Intention
Number of subjects: 0
Study 6493939 — intervention group
Group type: COMPARATOR
Intervention: Rational Self-statement
Number of subjects: 0
Study 6493939 — intervention group
Group type: COMPARATOR
Intervention: Expectancy Control
Number of subjects: 0
Study 30893236 — intervention group
Group type: EXPERIMENTAL
Intervention: Risk calculator incorporating 17 predictive variables for 90-day readmission after TJA
Number of subjects: 10155
Study 29286542 — intervention group
Group type: EXPERIMENTAL
Intervention: abstinence initiators (n=17)
Number of subjects: 78
Study 29286542 — intervention group
Group type: EXPERIMENTAL
Intervention: already abstainers (n=20)
Number of subjects: 78
Study 29286542 — intervention group
Group type: COMPARATOR
Intervention: continued drinkers (n=41)
Number of subjects: 78
Study 27881523 — intervention group
Group type: EXPERIMENTAL
Intervention: Culture-sensitive adapted material
Number of subjects: 435
Study 27881523 — intervention group
Group type: COMPARATOR
Intervention: Standard translated material
Number of subjects: 435
Study 24465565 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity exercise (H, midway between LT and VO2peak, 30 min)
Number of subjects: 26
Study 24465565 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-intensity exercise (M, @ lactate threshold (LT), 30 min)
Number of subjects: 26
Study 24465565 — intervention group
Group type: COMPARATOR
Intervention: Control (C, no exercise)
Number of subjects: 26
Study 22282154 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored nursing intervention (one nurse‐patient meeting before discharge with 2 additional contacts over 10 days, mean duration = 40 minutes per contact)
Number of subjects: 242
Study 22282154 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored nursing intervention
Number of subjects: 242
Study 22282154 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 242
Study 20227053 — intervention group
Group type: EXPERIMENTAL
Intervention: Rescue antenatal steroids
Number of subjects: 113
Study 20227053 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 113
Study 17598898 — intervention group
Group type: EXPERIMENTAL
Intervention: Mild induced hypothermia (MIH)
Number of subjects: 40
Study 16127467 — intervention group
Group type: EXPERIMENTAL
Intervention: Prototype Deep Clean manual toothbrush
Number of subjects: 60
Study 16127467 — intervention group
Group type: COMPARATOR
Intervention: ADA manual toothbrush plus floss
Number of subjects: 60
Study 16127467 — intervention group
Group type: COMPARATOR
Intervention: ADA manual toothbrush alone
Number of subjects: 60
Study 12352079 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonmechanical trephination
Number of subjects: 184
Study 12352079 — intervention group
Group type: COMPARATOR
Intervention: Mechanical trephination
Number of subjects: 184
Study 10520054 — intervention group
Group type: EXPERIMENTAL
Intervention: Active allergen-avoidance measures (Acarosan(R) and HDM-impermeable covers)
Number of subjects: 157
Study 10520054 — intervention group
Group type: COMPARATOR
Intervention: Placebo allergen-avoidance measures (water and cotton covers)
Number of subjects: 157
Study 10520054 — intervention group
Group type: EXPERIMENTAL
Intervention: Active allergen-avoidance measures
Number of subjects: 157
Study 7796587 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral contraceptive containing 30 mcg ethinylestradiol and 150 mcg desogestrel
Number of subjects: 783
Study 7796587 — intervention group
Group type: COMPARATOR
Intervention: Oral contraceptive containing 30 mcg ethinylestradiol and 75 mcg gestodene
Number of subjects: 783
Study 2442560 — intervention group
Group type: EXPERIMENTAL
Intervention: Lisinopril 5 mg daily (with option to increase to 10 or 20 mg)
Number of subjects: 130
Study 2442560 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 130
Study 31912141 — intervention group
Group type: EXPERIMENTAL
Intervention: 1:1 packed red blood cell to fresh frozen plasma transfusion ratio
Number of subjects: 68
Study 31912141 — intervention group
Group type: COMPARATOR
Intervention: 4:1 packed red blood cell to fresh frozen plasma transfusion ratio
Number of subjects: 68
Study 28965070 — intervention group
Group type: EXPERIMENTAL
Intervention: 10-min mindfulness exercise
Number of subjects: 86
Study 27484334 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet transfusion within 6 hours of symptom onset and 90 minutes of diagnostic brain imaging
Number of subjects: 190
Study 27484334 — intervention group
Group type: COMPARATOR
Intervention: Standard care without platelet transfusion
Number of subjects: 190
Study 27484334 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet transfusion
Number of subjects: 190
Study 24430095 — intervention group
Group type: EXPERIMENTAL
Intervention: Reprogramming of existing pacemakers to reduce RV pacing
Number of subjects: 66
Study 23385792 — intervention group
Group type: EXPERIMENTAL
Intervention: Lutein supplementation (10 mg Ester daily)
Number of subjects: 72
Study 23385792 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 72
Study 23385792 — intervention group
Group type: EXPERIMENTAL
Intervention: Lutein supplementation (10 mg Ester daily) in subgroup (n = 19)
Number of subjects: 72
Study 23385792 — intervention group
Group type: COMPARATOR
Intervention: Placebo in subgroup (n = 14)
Number of subjects: 72
Study 20435266 — intervention group
Group type: EXPERIMENTAL
Intervention: Quantitative ultrasound parameters (QUS) including amplitude‐dependent speed of sound (AD‐SoS), bone transmission time (BTT), US peak amplitude (UPA), signal dynamic (SDY), slope, energy, and fast wave amplitude (FWA)
Number of subjects: 101
Study 20435266 — intervention group
Group type: EXPERIMENTAL
Intervention: Quantitative ultrasound parameters (AD‐SoS, UPA, SDY, slope, energy)
Number of subjects: 101
Study 18250965 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiotherapy (RT) plus concomitant and adjuvant temozolomide
Number of subjects: 32
Study 19077388 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg oral pyridoxine thrice daily
Number of subjects: 92
Study 19077388 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 92
Study 15793163 — intervention group
Group type: EXPERIMENTAL
Intervention: procainamide plus levofloxacin
Number of subjects: 10
Study 15793163 — intervention group
Group type: EXPERIMENTAL
Intervention: procainamide plus ciprofloxacin
Number of subjects: 10
Study 15793163 — intervention group
Group type: COMPARATOR
Intervention: procainamide only
Number of subjects: 10
Study 16148965 — intervention group
Group type: COMPARATOR
Intervention: Treatment group received the 2000 version of the Medicare & You handbook; control group received no Medicare-related information.
Number of subjects: 3738
Study 16148965 — intervention group
Group type: COMPARATOR
Intervention: Re-mail group received a second copy of the handbook along with their mail survey instrument; no significant differences noted.
Number of subjects: 3738
Study 9210742 — intervention group
Group type: EXPERIMENTAL
Intervention: Happiness
Number of subjects: 12
Study 9210742 — intervention group
Group type: EXPERIMENTAL
Intervention: Sadness
Number of subjects: 12
Study 9210742 — intervention group
Group type: EXPERIMENTAL
Intervention: Disgust
Number of subjects: 12
Study 9210742 — intervention group
Group type: COMPARATOR
Intervention: Control conditions (film and recall)
Number of subjects: 12
Study 8359565 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous infusion of Sandostatin (SMS)
Number of subjects: 16
Study 8359565 — intervention group
Group type: COMPARATOR
Intervention: Oesophageal tamponade (OT)
Number of subjects: 16
Study 2444797 — intervention group
Group type: EXPERIMENTAL
Intervention: Felodipine (10 mg single dose)
Number of subjects: 9
Study 2444797 — intervention group
Group type: EXPERIMENTAL
Intervention: Felodipine (10 mg twice daily for 8 weeks)
Number of subjects: 9
Study 2444797 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study 11456286 — intervention group
Group type: EXPERIMENTAL
Intervention: Gliclazide 160 mg
Number of subjects: 12
Study 11456286 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 31491428 — intervention group
Group type: EXPERIMENTAL
Intervention: Shorter telomere length at follow-up (p=0.044)
Number of subjects: 1035
Study 31491428 — intervention group
Group type: EXPERIMENTAL
Intervention: Greater telomere attrition during follow-up (p=0.022)
Number of subjects: 1035
Study 31491428 — intervention group
Group type: COMPARATOR
Intervention: No similar associations found for men
Number of subjects: 1035
Study 30208070 — intervention group
Group type: EXPERIMENTAL
Intervention: Maintenance Care (MC)
Number of subjects: 328
Study 30208070 — intervention group
Group type: COMPARATOR
Intervention: Symptom-guided treatment (Control)
Number of subjects: 328
Study 27721545 — intervention group
Group type: EXPERIMENTAL
Intervention: Three options MCQ test
Number of subjects: 0
Study 27721545 — intervention group
Group type: COMPARATOR
Intervention: Four options MCQ test
Number of subjects: 0
Study 27721545 — intervention group
Group type: COMPARATOR
Intervention: Five options MCQ test
Number of subjects: 0
Study 24797121 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose opioid regimen (remifentanil effect-site concentration half of propofol)
Number of subjects: 120
Study 24797121 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose opioid regimen (remifentanil effect-site concentration double that of propofol)
Number of subjects: 120
Study 24797121 — intervention group
Group type: COMPARATOR
Intervention: Control group (no words played during anesthesia)
Number of subjects: 120
Study 22932261 — intervention group
Group type: EXPERIMENTAL
Intervention: Health education intervention (45-minute conference-style training)
Number of subjects: 148
Study 22932261 — intervention group
Group type: COMPARATOR
Intervention: Control group (no health education)
Number of subjects: 148
Study 22932261 — intervention group
Group type: EXPERIMENTAL
Intervention: Health education intervention
Number of subjects: 148
Study 20530294 — intervention group
Group type: COMPARATOR
Intervention: Control (bed rest without exercise)
Number of subjects: 18
Study 20530294 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistive exercise
Number of subjects: 18
Study 20530294 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistive vibration exercise
Number of subjects: 18
Study 17634269 — intervention group
Group type: EXPERIMENTAL
Intervention: Medox (anthocyanin supplementation, 300 mg/d for 3 weeks)
Number of subjects: 120
Study 17634269 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study 16334439 — intervention group
Group type: EXPERIMENTAL
Intervention: Metronidazole (5 days)
Number of subjects: 16
Study 16334439 — intervention group
Group type: EXPERIMENTAL
Intervention: Metronidazole (5 days) + Oligofructose (12 days)
Number of subjects: 16
Study 16334439 — intervention group
Group type: EXPERIMENTAL
Intervention: Oligofructose (12 days)
Number of subjects: 16
Study 12498337 — intervention group
Group type: EXPERIMENTAL
Intervention: Stimulant medication
Number of subjects: 18
Study 9811916 — intervention group
Group type: EXPERIMENTAL
Intervention: Carotid endarterectomy
Number of subjects: 2226
Study 9811916 — intervention group
Group type: COMPARATOR
Intervention: Medical care
Number of subjects: 2226
Study 7665416 — intervention group
Group type: EXPERIMENTAL
Intervention: Added fat and protein (FP) diet (C diet + 1.6 g.kg‐1.day‐1 fat + 1.2 g.kg‐1.day‐1 protein)
Number of subjects: 8
Study 7665416 — intervention group
Group type: COMPARATOR
Intervention: Control (C) diet (high glycemic index CHO foods; CHO = 7 g.kg‐1.day‐1)
Number of subjects: 8
Study 7665416 — intervention group
Group type: EXPERIMENTAL
Intervention: Matched-energy diet (C diet + 4.8 g.kg‐1.day‐1 additional CHO)
Number of subjects: 8
Study 7665416 — intervention group
Group type: EXPERIMENTAL
Intervention: Added fat and protein (FP) diet
Number of subjects: 8
Study 2550243 — intervention group
Group type: EXPERIMENTAL
Intervention: Isradipine (IS)
Number of subjects: 18
Study 2550243 — intervention group
Group type: COMPARATOR
Intervention: Placebo (P)
Number of subjects: 18
Study 1103333 — intervention group
Group type: EXPERIMENTAL
Intervention: Adriamycin
Number of subjects: 39
Study 1103333 — intervention group
Group type: COMPARATOR
Intervention: Melphalan
Number of subjects: 39
Study 31282686 — intervention group
Group type: EXPERIMENTAL
Intervention: Trier Social Stress Test (psychosocial stress induction)
Number of subjects: 122
Study 31282686 — intervention group
Group type: COMPARATOR
Intervention: Placebo version (active control)
Number of subjects: 122
Study 29183931 — intervention group
Group type: EXPERIMENTAL
Intervention: Early low-energy enteral nutrition (10 kcal/kg/day)
Number of subjects: 220
Study 29183931 — intervention group
Group type: COMPARATOR
Intervention: High-energy enteral nutrition (25 kcal/kg/day)
Number of subjects: 220
Study 25203688 — intervention group
Group type: EXPERIMENTAL
Intervention: 39 g·hr(‐1) carbohydrate (CHO)
Number of subjects: 20
Study 25203688 — intervention group
Group type: EXPERIMENTAL
Intervention: 64 g·hr(‐1) carbohydrate (CHO)
Number of subjects: 20
Study 25203688 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 g·hr(‐1) carbohydrate (CHO)
Number of subjects: 20
Study 25203688 — intervention group
Group type: COMPARATOR
Intervention: 0 g·hr(‐1) control (water)
Number of subjects: 20
Study 24687355 — intervention group
Group type: EXPERIMENTAL
Intervention: Infant formula added with a dual prebiotic system 'Metlin® and Metlos®' from Mexican agave
Number of subjects: 600